// App-Quantinova.ai

OP004 : The optimal duration of dual antiplatelet therapy after drug-eluting stent: a risk-benefit analysis using Bayesian Network meta-analysis of randomised controlled trials

Researchers

Presenter

  • Sethi A

Principal Investigators

  • Ismail I

  • Khosla S

  • Arora R

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved